These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1790050)

  • 1. Variability in cholesterol measurements in a worksite cholesterol screening program.
    Stave GM; Winslow BS; Conner GW
    Am J Prev Med; 1991; 7(6):406-9. PubMed ID: 1790050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Logistical implementation of cholesterol screening at the worksite. Appointment versus walk-in approach.
    Nielsen MM
    AAOHN J; 1991 May; 39(5):235-40. PubMed ID: 2025334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variation in serum cholesterol level in the same person: what is the true value and when is it called a significant change?].
    Hendriksen IJ; Bezemer PD; Boerma GJ; Zuiderveld U
    Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1507-11. PubMed ID: 1495568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of the IMPACT worksite cholesterol reduction program.
    Fielding JE; Mason T; Kinght K; Klesges R; Pelletier KR
    Am J Prev Med; 1995; 11(2):120-3. PubMed ID: 7632447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
    Bookstein L; Gidding SS; Donovan M; Smith FA
    Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetes prevention program: a worksite experience.
    Aldana SG; Barlow M; Smith R; Yanowitz FG; Adams T; Loveday L; Arbuckle J; LaMonte MJ
    AAOHN J; 2005 Nov; 53(11):499-505; quiz 506-7. PubMed ID: 16309012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum total cholesterol levels over 18 years in a cohort of men and women: The Nijmegen Cohort Study.
    Bakx JC; van den Hoogen HJ; Deurenberg P; van Doremalen J; van den Bosch WJ
    Prev Med; 2000 Feb; 30(2):138-45. PubMed ID: 10656841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of analytical quality and preanalytical variations on measurements of cholesterol in screening programmes.
    Petersen H; Larsen ML; Hörder M; Blaabjerg O
    Scand J Clin Lab Invest Suppl; 1990; 198():66-72. PubMed ID: 2189210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lucent-Takes-Heart cardiovascular health management program. Successful workplace screening.
    Guico-Pabia CJ; Cioffi L; Shoner LG
    AAOHN J; 2002 Aug; 50(8):365-72. PubMed ID: 12227211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives.
    Kjos SL; Gregory K; Henry OA; Collins C
    Obstet Gynecol; 1993 Dec; 82(6):925-30. PubMed ID: 8233266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total cholesterol, HDL-cholesterol and blood pressure in relation to life style: results of the first population screening of the Swiss MONIKA Project].
    Marti B; Dai S; Rickenbach M; Wietlisbach V; Bucher C; Barazzoni F; Gutzwiller F
    Schweiz Med Wochenschr; 1990 Dec; 120(51-52):1976-88. PubMed ID: 2274764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated serum lipid measurements during the peri-hospitalization period.
    Nawaz H; Comerford BP; Njike VY; Dhond AJ; Plavec M; Katz DL
    Am J Cardiol; 2006 Nov; 98(10):1379-82. PubMed ID: 17134633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
    Milani RV; Lavie CJ
    Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A supermarket cardiovascular screening program: analysis of participants' solicitation of follow-up care.
    Strychar IM; Potvin L; Pineault R; Pineau R; Prévost D
    Am J Prev Med; 1994; 10(5):283-9. PubMed ID: 7848671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid screening in a managed care population.
    Davis KC; Cogswell ME; Rothenberg SL; Koplan JP
    Public Health Rep; 1998; 113(4):346-50. PubMed ID: 9672575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.